Brompheniramine Maleate (CAS# 980-71-2) Stage- R & D Trials

Indian manufacturer of Brompheniramine Maleate (CAS 980-71-2). Schedule-M compliant antihistamine API supplier for global pharma markets.

Product Description
Brompheniramine Maleate is a well-established antihistamine used for the relief of allergic conditions, including rhinitis, urticaria, and common cold symptoms. It is commonly formulated in tablets, syrups, capsules, and combination cold & flu products.

______________________________________________________________________________________________________________

क्रम संख्या

S. No.

विशेषताएँ

Characteristics

विशेष विवरण

Specification

1

विवरण (यूएसपी)
Description

एक सफेद क्रिस्टलीय गंधहीन पाउडर
A white crystalline odourless powder

2

इन्फ्रा-रेड (यूएसपी/पीएचईयूआर)
INFRA-RED (USP/PhEur)

संदर्भ स्पेक्ट्रम के अनुसार
Conforms to reference spectrum

3

एचपीएलसी (यूएसपी)
HPLC (USP)

सैंपल सॉल्यूशन में मेलिक एसिड और ब्रोमफेनिरामाइन के पीक का रिटेंशन टाइम मानक सॉल्यूशन के साथ मेल खाता है, जैसा कि असे में प्राप्त होता है
The retention time of the maleic acid and brompheniramine peaks of the Sample Solution correspond to those of the Standard Solution, as obtained in the Assay

4

पीएच (पीएच यूरो/यूएसपी)
pH (Ph Eur/USP)

४.०-५.०
4.0-5.0

5

सुखाने पर हानि (यूएसपी/पीएचईयूआर)
LOSS ON DRYING (USP/PhEur)

≤ ०.५%
≤ 0.5%

_______________________________________________________________________________________________________________

Chemical Name: Brompheniramine Maleate
CAS Number: 980-71-2
Molecular Formula: C₁₆H₁₉BrN₂·C₄H₄O₄
Category: Pharmaceutical Active Ingredient (API)
Therapeutic Class: Antihistamine (H₁ receptor antagonist)
Stage: R & D Trials
Manufacturing Origin: India

_______________________________________________________________________________________________________________

Applications of Brompheniramine Maleate

  • Antiallergic Formulations

  • Cold & Cough Combination Products

  • Rhinitis & Upper Respiratory Treatments

  • Tablet, Syrup, and Capsule Manufacturing

  • Export-Oriented Finished Dosage Forms